Skip to main content
EYPT
NASDAQ Industrial Applications And Services

EyePoint Seeks Shareholder Approval for 4.9M Share Increase in Incentive Plan, Potentially Diluting Existing Holders

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$13.6
Mkt Cap
$1.135B
52W Low
$5.3
52W High
$19.11
52W Position info
157% above low
Off High info
29% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

EYPT has more than doubled off its 52-week low of $5.3.

Summary

EyePoint, Inc. filed its definitive proxy statement for its annual meeting, seeking approval for a 4.9 million share increase in its equity incentive plan, which could lead to significant dilution for existing shareholders.


Key Events · Corporate Governance and Compliance · EYPT

  • Proposed Equity Plan Expansion

    Shareholders are asked to approve an amendment to the 2023 Long-Term Incentive Plan, increasing the number of shares authorized for issuance by 4,900,000. This represents a potential dilution of approximately 5.85% of current outstanding shares.

  • Board Composition Change

    Director Nancy Lurker will not stand for re-election at the Annual Meeting, which will reduce the Board of Directors from nine to eight members.

  • Annual Shareholder Meeting Set

    The 2026 Annual Meeting of Stockholders will be held virtually on June 18, 2026, to vote on director elections, the incentive plan amendment, executive compensation, and auditor ratification.


Analysis · EYPT · Industrial Applications And Services

EyePoint, Inc. has filed its definitive proxy statement for its upcoming annual meeting, highlighting a proposal to increase the shares authorized under its 2023 Long-Term Incentive Plan by 4.9 million. This proposed increase represents a potential dilution of approximately 5.85% of the company's current outstanding shares. While the company states this is crucial for attracting and retaining talent in a highly competitive biotech market, such a significant expansion of the equity pool could create an overhang on the stock. Shareholders will also vote on the re-election of directors, an advisory resolution on executive compensation, and the ratification of the independent auditor.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EYPT was trading at $13.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $5.30 to $19.11. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EYPT - Latest Insights

EYPT
Nov 12, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.350
Real-time Price: $0.3102 info
Change: -$0.0398 (-11%) info
Market Cap: $34.817M info
EYPT
Nov 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.360
Real-time Price: $0.3102 info
Change: -$0.0498 (-14%) info
Market Cap: $34.817M info
EYPT
Nov 12, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.360
Real-time Price: $0.3102 info
Change: -$0.0498 (-14%) info
Market Cap: $34.817M info
EYPT
Oct 19, 2026, 9:22 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5443
Real-time Price: $0.3102 info
Change: -$0.2341 (-43%) info
Market Cap: $34.817M info
EYPT
Oct 19, 2026, 8:08 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.6115
Real-time Price: $0.3102 info
Change: -$0.3013 (-49%) info
Market Cap: $34.817M info